| Trial ID: | L0848 |
| Source ID: | CTRI/2016/04/006847
|
| Associated Drug: |
Saberry capsules
|
| Title: |
An open label clinical study to evaluate the efficacy and safety of Saberry capsules in adult male or female patients suffering from Non-alcoholic Fatty Liver Disease.
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Health Condition 1: K758- Other specified inflammatory liverdiseases
|
| Interventions: |
Intervention1: Saberry????: One capsule once a day for a period of 90 days.<br>Control Intervention1: NIL: NIL<br>
|
| Outcome Measures: |
1 Complete Liver Profile <br/ ><br>2 Anti oxidant enzymes <br/ ><br>3 Haematology for immuno stimulation <br/ ><br>4 Complete Lipid Profile <br/ ><br>5 Glycaemic Profile <br/ ><br>6 Chronic Liver Disease QuestionnaireTimepoint: 1 Complete Liver Profile <br/ ><br>2 Anti oxidant enzymes <br/ ><br>3 Haematology for immuno stimulation <br/ ><br>4 Complete Lipid Profile <br/ ><br>5 Glycaemic Profile <br/ ><br>6 Chronic Liver Disease Questionnaire1 Adverse events <br/ ><br>2 Abnormal vital signsTimepoint: 1 Adverse events[Day 30,Day 60 & Day 90] <br/ ><br>2 Abnormal vital signs[Screening, Day 0,Day 30,Day 60 & Day 90]
|
| Sponsor/Collaborators: |
Sami Labs Limited
|
| Gender: |
--
|
| Age: |
nannan
|
| Phases: |
Not applicable
|
| Enrollment: |
24
|
| Study Type: |
Interventional
|
| Study Designs: |
Single Arm Trial<br> Method of generating randomization sequence:Not Applicable Method of allocation concealment:Pre-numbered or coded identical Containers Blinding and masking:Not Applicable
|
| Start Date: |
19/04/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
24 November 2021
|
| Locations: |
India
|
| URL: |
http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=14466
|
